Concomitant cisplatin and radiotherapy in a conventional and modified fractionation schedule in locally advanced head and neck cancer: a randomised phase II EORTC trial.

Bartelink, H; Van den Bogaert, W; Horiot, J-C; Jager, J; van Glabbeke, M

Bartelink, H; Van den Bogaert, W; Horiot, J-C; Jager, J; van Glabbeke, M.

Affiliation

Bartelink H; The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. h.bartelink@nki.nl

Eur J Cancer ; 38(5): 667-73, 2002 Mar.

Article in En | MEDLINE | ID: mdl-11916549

Subject(s)

Antineoplastic Agents/therapeutic use; Cisplatin/therapeutic use; Head and Neck Neoplasms/drug therapy; Head and Neck Neoplasms/radiotherapy; Radiation-Sensitizing Agents/therapeutic use; Antineoplastic Agents/adverse effects; Cause of Death; Cisplatin/adverse effects; Combined Modality Therapy; Dose Fractionation, Radiation; Drug Administration Schedule; Feasibility Studies; Female; Head and Neck Neoplasms/pathology; Humans; Male; Radiation Injuries/etiology; Radiation-Sensitizing Agents/adverse effects; Radiotherapy/adverse effects; Radiotherapy Dosage; Recurrence; Survival Rate

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Radiation-Sensitizing Agents / Cisplatin / Head and Neck Neoplasms / Antineoplastic Agents Type of study: Clinical_trials / Etiology_studies Limits: Female / Humans / Male Language: En Journal: Eur J Cancer Year: 2002 Document type: Article Affiliation country: Netherlands

Search on Google

Add to My VHL

XML

PubMed Links